problems. In this paper, we focus on the last problem. In particular, we try to explain why some peptides produce peaks of p a t intensity, while others produce peaks of low intensity, and we treat this as a classification problem. That is, we experimentally evaluate and compare a variety of discrimination methods for classifying peptides into those that produce high-intensity peaks and those that produce low-intensity peaks. The methods considered include K-Ne& Neighbours (KNN), Logistic Regression, Linear Discriminant Analysis (LDA), Quadratic Discriminant Analysis (QDA), Naive Bayes, and Hidden Markov Models (HMMs). Experiments using these methods were conducted on three real-world datasets derived from tissue samples of Mouse. The methods welp then evaluated using ROC curves and evalidation.
and Han Liu peak intensities. One important factor is clearly the amount of protein input to the mass spectrometer (since more input implies more output). However, other factors are important as well, such as the efficiency with which various peptides are produced, fractionated and ionized. Our goal is to determine how all these other factors are influenced by a peptide's aminoacid sequence. Once these influences are understood, it may be possible to predict the exact MSMS spectrnm of a protein, including the intensities of all its peaks. More importantly, it may also be possible to solve the inverse problem: given the MSNS spectrum of a protein, estimate the amount of protein that was input to the mass spectrometer. This is a fundamental problem whose solution would enable biologists to determine the levels of the thousands of proteins in a tissue sample [2] , As a first step in explaining why different peptides produce peaks of different intensity, we reduce the problem to its simplest terms: explaining why some peptides produce peaks of great intensity, while others produce peaks of low intensity. Moreover, we treat this as a classification problem. That is, given the amino-acid sequence of a peptide, we attempt to classify the peptide ils either high-intensity or low-intensity. If we can do this reliably, then we have effectively discovered what it is about the amino-acid sequence of a peptide that determines whether it produces high-or low-intensity peaks. This is especially trne if the parameters of the classifier can he interpreted biologically. To tackle this classification problem, this paper evaluates and compares a variety of classification methods on M S m S data. Conducting the evaluation involves three main steps: producing a set of labeled data, training a number of different classifiers on a pottion of the data (the "training data"), and evaluating the effectiveness of the classifiers on the remaining data (the "testing data").
To produce a labeled set of data. we first obtained a set of several thousand MSMS spectra.' From these spectra, we produced two classes of peptides, those with high-intensity peaks, and those with low-intensity peaks. One complication is that in the high-throughput M S N S experiments from which the data was derived, the amount of protein input to the mass spectrometer is unknown. Thus, it is in general unclear whether a high-intensity peak is due lo the properties of the peptide (which we are interested in) or simply due to a large amount of protein at the input (which we are not interested in). We resolved this problem by focusing on the spectra one protein at a time. In the spectrum of a single protein, all the ' C o u m~y of the Emili Laboratory at the Bmting and Best Depvfment of U].
Medical Research at the University of Toronto 0-7803-8728-7104/S20.00 02004 IEEE I60 peaks are derived from the same (unknown) amount of protein, so differences in peak intensity are not due to differences in protein input. In this way, by picking the highest and lowest peaks in each spectrum, we produced two classes of peptides, one class labeled "high intensity" and the other labeled "low intensity".
Since this is an initial study, we chose a number of basic classification methods which are extensively used in the datamining literature: K-Nearest Neighbours (KNN), Logistic Regression, Linear Discriminant Analysis (LDA), Quadratic Discriminant Analysis (QDA), Naive Bayes, and Hidden Markov Models (HMMs). Most of these methods have also been used in the context of micromay data to distinguish various cancer types [5]. To evaluate the methods for our application, we first trained them on two thirds of the labeled data, and then evaluated them on the remaining one third. To compare the methods, we produced both ROC curves and a table of classification error rates. In general, classification error rates depend on the size of the labeled classes, and can be deceptively low when the classes have very different sizes (as ours do, since most peptide peaks are low-intensity, not high-intensity), To compensate for this. we used the ROC data to estimate classification error rates for classes of equal size. In addition, the ROC curves themselves are insensitive to differences in class size. In this way, we can compare the performance of the classifiers on various data sets without having to worry about variations in class size. The ROC curves also allow us conveniently to compare classifiers for many different values of a discriminant threshold parameter. To assess variability in performance, we generated a number of ROC curves for each method using 10-fold cross validation.
Finally, it is worth noting that of the six classification methods we chose to evaluate, three are designed for classifying vectors (LDA, QDA and Logistic Regression), two are most-easily applied to vectors (K" and Naive Bayesj, while only the last (HMM) is specifically designed for classifying sequences. HMMs can therefore be applied directly to the amino-acid sequences of peptides. To apply the other five methods, we first converted the peptide sequences to feature vectors. Since there is a certain loss of information in this conversion, one might expect HMMs to perform the best, especially since they have achieved considerable success in other areas of sequence classification, such as speech recognition [I71 and DNA sequence analysis [15]. Surprisingly. we found that for our peptide-classification problem, HMMs performed the worst. We discuss reasons for this in Section V.
The paper is organized as follows: Section 11 introduces Peptide Tandem Mass Spectrometry; Section III reviews the six classification methods we evaluate: Section N describes our data and our experimental design; Section V presents and discusses our experimental results: and Section VI presents conclusions.
PEPTIDE TANDEM MASS SPECTROMETRY
In Tandem Mass Spectrometry, a mixture of tens of thousands of unknown proteins are taken from a tissue sample. By adding a specific amount of the enzyme trypsin, the proteins are digested and fragmented into peptides. The resulting mixture is then fractionated, ionized and sent at high speed through an electric field, where the paths of the different peptides are bent by different amounts before hitting a plate. This produces a so-called "mass spectrum" consisting of various peaks. Each peak occurs at a particular location on the plate, as determined by the peptide's mass-to-charge ratio, and the intensity of the peak represents the number of peptide molecules to hit the plate at that location [161, [121, [I] .
The intensity of a peak is influenced by the amount of protein in the input mixture. However, the exact mechanism determining the intensity of a spectral peak is poorly understood [XI. In an ideal experiment, there would be no loss during digestion, fractionation and ionization. So, in the MS/MS spectrum for a given protein, one would expect that each peak would contain one peptide molecule for each protein molecule in the input. Consequently, an ideal spectrum for a given protein would consist of peaks of equal intensity. However, this is not observed experimentally. Figure I illustrates the differences between an ideal MS/MS spectrum and an experimental one. [181. An obvious factor influencing peak intensity is the concentration of the peptides in the sample. However, it is not the sole factor. Other factors include sample preparation methods, the pH and composition of the solution containing the protein mixture, the characteristics of the M S N S apparatus. and the characteristics of the tissue sample being analyzed [XI. These factors and others all affect the intensities of peaks in a M S N S spectrum. Unfortunately, no model exists for accurately predicting these peak intensities. Explaining why some peptides produce high-intensity peaks and some produce low-intensity peaks is a first step towards developing such a model, and is the goal of this paper.
To this end, the Emili Laboratory at the Banting and Best Department of Medical Research at the University of Toronto has provided us with several thousand MSlMS spectra. Table I shows a tiny sample of this data. (Details on how this data 
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was generated can be found in [ZI] .) The first column in the table is the Swissprot accession number identifying a protein.
The second column is the amino-acid sequence of a peptide fragmented from the protein. The third column correlates well with the intensity of the spectral peak produced by the peptide.
(Its values are integers because it represents a count of peptide molecules.) The last column represents the charge of the peptide ion, which is typically I or 2. Notice that there may be many entries for the same protein, since a single protein can produce many peptides.
In fragmenting the proteins to produce peptides, the proteins were digested by the enzyme trypsin, which cuts c-terminal to lysine (K) or arginine (R). Trypsin may occasionally cut at other locations, and other enzymes may nick the protein; hence. we sometimes see partial tryptic peptides (a K or R at the c-terminus, or flanking the peptide at the N-terminus).
DISCRIMINATION METHODS
This section outlines the classification methods used in our study. Each of the methods can be used to assign objects to one of several classes, though we use them in a strictly binary mode, to assign peptides to one of two classes, which we refer to simply as Class 1 and Class 2, respectively. In our application, Class 1 is the set of peptides that produce highintensity peaks, and Class 2 is the set of peptides that produce low-intensity peaks. How the peptides are represented depends on the classification method used. For one of the methods (Hidden Markov Models), each peptide is represented by its amino-acid sequence. For the remaining methods, each peptide is represented by a vector, x, of features extracted from the sequence. How these features are extracted is described in Section IV.
All the classification methods used in this study produce classifiers that are discriminative [13] , [14] , [20] . That is, given an object, the classifier produces a score or likelihood, P I , that the object belongs to Class 1, as well as a score, yr, that it belongs to Class 2. An object is assigned to Class 1 if and only if p , f p z > 1, where 1 is a decision threshold. a ) Naive Bayes: Most of the classification methods used in this paper are based on Bayes Rule. They differ primarily in their assumptions about the prior probabilities, f k ( x ) . In the Naive Bayes classifier, it is assumed (simplistically) that the features of the vector x can he treated as independent random variables. Thus, if x = (21, ..., z"). then where f k i ( z , ) is the (marginal) probability of zi for class k.
In our application, the components of the feature vector, x, are discrete (as we shall see), and the most common values are 0 and 1, so we use binary distributions to estimate f k i . For each class, Bayes Rule is then used to compute the posterior probability that x belongs to the class. b) Linear Discriminant Analysis: In Linear Discriminant Analysis (LDA), each class is modeled by a multivariate Gaussian distribution, where each class is assumed to have the same covariance matrix. In fining the Gaussian distributions to the data, LDA produces maximum likelihood estimates for several parameters: Kk, the prior probability of class k; pk, the mean of class k; and C, the common covariance matrix. Because the class distributions are Gaussian and the covariance matrices are equal, the likelihood ratio test reduces to a particularly simple form: x w > t , where t is a decision threshold, w is a parameter vector computed from C, p~ and pz, and denotes the inner product of two vectors [9] . The decision boundary between the two classes is therefore linear, and more specifically, a hyperplane normal to w. c ) Quadratic Discriminant Analysis: Quadratic Discriminant Analysis (QDA) is a generalization of LDA that does not assume the classes have the same covariance matrix. In this case, the decision boundary between the two classes is not linear but quadratic, and can in general he a hypersphere, a hyperellipsoid, a hyperparaboloid, a hyperhyperboloid, or any combination thereof [4] .
d ) Logistic Regression: Like QDA, Logistic Regression can be viewed as a generalization of LDA. However, whereas QDA has more parameters than LDA, Logistic Regression has fewer. Like LDA, Logistic Regression provides a linear decision boundary between classes. The main difference is that Logistic Regression is in a sense more direct. Instead of first fitting multivariate Gaussians to each class (which requires estimating O ( n 2 ) parameters), Logistic Regression fits a linear decision boundary directly to the data (which requires estimating only n parameters, where n is the dimension of the feature space).
e ) K-Nearest Neighbors: K-Nearest Neighbors (KNN) is different from the other methods considered in this paper in that it is non-parametric, so there are no parameters to estimate. To classify an object, x, the method finds the K objects (or neighbors) in the training data that are closest to it. The object is then assigned to Class 1 if and only if K I I K 2 > t, for some decision threshold, 1. Here, h', is the number of K-nearest neighbors in Class 1, and K z is the number in Class 2 (so K1 + Kz = K ) . To use K", one must choose a measure of "distance" (or similarity) between two objects. This paper uses Euclidean distance.
fl Hidden Markov Models: A (first-order) Hidden
Markov Model (HMM) is a finite-state automaton in which each state transition has a probability. In addition. each state has a set of outputs symbols, each with an associated probability. When an HMM is in a given state, it chooses an output symbol probabilistically. and prints it. Efficient algorithms have been developed for HMMs. For instance, given a sequence, s, and a HMM, inference algorithms compute the probability, ~( s ) , that s will be generated by the HMM. Leaming algorithms also exist for HMMs. Given a set of sequences, these algorithms will find the HMM with a given number of states that is most likely to generate the set.
IV. DATASETS AND STUDY DESIGN
A. Real-world Datasets
The experimental results in this paper are based on a number of tables of real-world data similar to Table I . They consist of three datasets derived from tissue samples taken from Mouse and were provided by the Emili Lab in the Banting and Best Department of Medical Research at the University of Toronto. We refer to these data sets as Mouse Brain Data, Mouse Heart Data, and Mouse Kidney Data. The Brain data set contains 10,786 peptides, with peak intensities ranging from 1 to 2,500; the Heart data set contains 9,623 peptides, with peak intensities from 1 to 1,996; and the Kidney data set contains 8,791 peptides, with peak intensities from 1 to 1,491.
B. Study Design
As described in Section I, we divide the peptides in the training data into two classes, those that produce high-intensity peaks, and those that produce low-intensity peaks. One complication is that in the high-throughput M S N S experiments from which the data was derived, the amount of protein input to the mass spectrometer is unknown. Thus, it is in general unclear whether a high-intensity peak is due to the properties of the peptide (which we are interested in) or simply due to a large amount of protein at the input (which we are not interested in). We resolved this problem by focusing on the spectra one protein at a time. In the specmm of a single protein, all the peaks are derived from the same (unknown) amount of protein, so differences in peak intensity are not due to differences in protein input. In this way, by picking the highest and lowest peaks in each spectrum, we can factor out the effect of protein input levels.
To do this, we first identified those proteins that have at least two peptides with observable peaks in their spectra. We then built an index for these proteins, and a separate index for their peptides. For the Brain dataset, the indexes contain 8,527 peptides and 1,664 proteins, respectively. For the Heart dataset, the indexes contain 7,660 peptides and 1,281 proteins, respectively. For the Kidney dataset, the indexes contain 7,074 peptides and 1,291 proteins, respectively. For each protein, we then picked the peptides with the highest and lowest spectral peaks. Moreover, we did this only for proteins with a wide range of peak intensities, so that we could be sure of obtaining peptides with genuinely lowand high-intensity peaks. We did this in two different ways, producing two pairs of peptide classes, which we call MAX-MIN and STD-DEV, respectively. The two pairs differ only in the proteins selected. For MAX-MIN, a protein is selected if ( i ) the most intense peak in its spectrum has a count greatex than 12, and (ii) the count of this highest peak is at least 12 times greater the count of the lowest peak. For the STD-DEV, a protein is selected if the standard deviation of all its peak intensities is greater than 4. Both MAX-MIN and STD-DEV contain two classes of peptides, one with high-intensity peaks, and one with low-intensity peaks. In MAX-MIN, the two classes of peptides are guaranteed to have very different peak intensities, since the high-intensity peaks are guaranteed to be at least 15 times greater than the low-intensity peaks.
In STD-DEV, the peptides in the two classes do not always have such a great difference in peak intensity, but they contain more peptides, i.e., more data on which to train and test the classifiers. In this way, from the original, unlabeled Kidney dataset, we generated two labeled datasets, one using MAX-MIN and one using STD-DEV. Likewise for the Heart and Brain datasets, for a total of six labeled datasets.
The sizes of the datasets generated by the MAX-MIN method are as follows: the Brain dataset has 658 peptides in the "high intensity" class, and IS67 in the "low intensity " class; the Heart dataset has 389 peptides in the "high intensity" class, and 1232 in the "low intensity " class; the Kidney dataset has 470 peptides in the "high intensity" class, and 1,211 in the "low intensity " class. The sizes of the datasets generated by the STD-DEV method are as follows: the Brain dataset has 818 peptides in the "high intensity" class, and 1,735 in the "low intensity " class; the Heart dataset 463 peptides in the "high intensity" class, and 1,297 in the "low intensity " class; the Kidney dataset has 550 peptides in the "high intensity" class, and 1,327 in the "low intensity " class; We estimated the generalization error of the methods in two ways. In the first approach, we divided each of the six labeled datasets randomly into training and testing data, in a 2: 1 ratio. We then trained and tested each classification method on each of the six datasets. The results show the variation in performance of the methods over different datasets and different data-generation methods. In the second approach, we used only one of the six datasets: the Kidney dataset generated by STD-DEV. On this dataset, we did IO-fold cross validation for each classification method. The results show the variation in performance of each method over different splits in the dataset.
Finally, for many of the classification methods used in this study, we must represent each peptide as a vector, x. We have two ways of doing this, using vectors with 21 and 421 components, respectively. The 21-component vectors represent the amino-acid composition of a peptide. Since there are twenty different amino acids, the vector has 20 components, (ZI, ..., 520). where the value of zi is the number of occurrences a particular amino acid in the peptide. In addition, the vector has a 21st , 20, whose value is always I, to represent a bias term, as is common in machine learning models [9] . The 421-component vector includes the original 21 components plus 400 more representing the dimer composition of a peptide. A dimer is a sequence of two amino acids, and since there are 20 distinct amino acids, there are 400 distinct dimers. This, larger vector representation was used only with the Naive bayes classifier, because of its reputation for working well in high dimesnions. The other vector-based classifiers were used only with 21-component vectors, to prevent overfitting. For comparison purposes, Naive Bayes was sometinmes also used with this shorter vector representation.
v. RESULTS AND ANALYSIS
Figures 2 through 5 show ROC curves evaluating the performance of each of the classification methods under various conditions. Following the convention given in [9] , the honzonlal axis of our ROC curves is specificity, and the vertical axis is sensitivity. In our case, specificity is the probability that a peptide with high-intensity peaks is predicted to have high-intensity peaks. Likewise, sensitivity is the probability that a peptide with low-intensity peaks is predicted to have low-intensity peaks. Each ROC curve colresponds to a single classification method, and each point in an ROC curve corresponds to the method being used with a different decision threshold.
based classifiers in this figure used 21-component vectors. Figure 4 shows the results of cross validation on each of the six methods. Here, K" is used with K=50, and HMM is used with a single state, the values for which they performed best in the earlier experiments. Each of the six subfigures contains ten ROC curves, one for each run of IO-fold cross validation. The one exception is the subfigure for the Naive Bayes classifier, which contains twenty ROC curves, ten for Naive Bayes used with 21-component vectors, and ten for 421-component on the heart dataset, where IO-" performs better. Likewise, HMM performs hest when it has only I state, except on the brain dataset, where it performs best with 5 states. Figure 3 shows ROC curves for all six classification methods on all six labeled datasets. In the top half of the figure, the datasets were generated by the MAX-MIN method. In the bottom half, they were generated by the STD-DEV method. Except for Naive Bayes, which used the 421-component vectors, all the vectorHidden Markov Models, with different values for K and due to the of the data into training and A.
From the ROC curves, several conclusions are immediately apparent: (i) LDA performs the hest, (ii) Hidden Markov Models perform the worst, (iii) the variability in the other methods is large compared to the differences in their average "rves performance, and (zu) except for HMM, a11 the methods performed better with a 9:l split of training to testing data than with a 2:1 split. This last observation is probably due to the larger portion of training data available in the 9 I split.
The simple LDA method produced impressively better performance than other, more-sophisticated methods, such as QDA and especially Hidden Markov Models. With the exception of the Mouse Kidney dataset generated by STD-DEV, on which Logistic Regression performed best, LDA performed better than all other methods on all datasets. Many of the other methods appear to be overfitting, which may be why their performance on the testing data is worse than LDA. For example, since QDA has almost twice as many parameters as LDA, it may be overfitting. Likewise, Logistic Regression is more general than LDA and can require about 30% more data to obtain the same fit [9] .
Although it is hard to rank methods other than LDA and HMM, it should be noted that Naive Bayes performed better with 421-component vectors than with 21-component vectors. This is apparent both in Figure 5 and in Figure 4 . Of course, more parameters can always lead to a better fit on the training data, and with only IO00 to 1500 training points, Naive Bayes is in danger of overfitting when used with 421-component vectors. So, it is surprising that it performs well on the testing data, living up to its reputation of performing well in highdimensional spaces. It may be possible to further improve the performance of Naive Bayes by using more-complex prior dishibutions for the individual features. At present. we use binary distlibutions. Since each feature represents an aminoacid count, a binary distribution effectively means that each amino acid is modeled as being either present or absent in a peptide. This represents a loss of information, which morecomplex prior distributions could eliminate.
To our surprise, Hidden Markov Models performed the worst of all the classification methods: sometimes even worse than randomly guessing. This is despite the fact that they work directly on the peptide sequences, and not on vectors with lower information content. One reason seems obvious from the ROC curves in Figure 2 . These show that performance generally degrades as the number of states in the HMM increases. This is a sure sign of overfitting. In fact, a HMM with IO states will have 10 + 10' + 10 x 20 = 310 parameters.
The factor of 20 comes from the 20 amino acids that each of the 10 states must be able to output. Since the classes in our training data often have only about 300 samples, over fitting is surely taking place. Even with only 5 states, the number of parameters is 5 + 5' + 5 x 20 = 130, which is still too many. In addition to this, HMMs only capture the pmportion of amino acids in a peptide sequence. In particular, with only a small number of states, they cannot capture the m. absolute number of amino-acid occurrences, as our vectors do. It seems reasonable to suppose that the actual presence of a particular number of cettain acids may be an important factor in the ionization of peptides. In fact, in a separate experiment, we used vectors whose components represented amino-acid proportions, instead of absolute numbers, and this caused the performance of Logistic Regression to decrease greatly, to about the same level as HMMs.
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B. Classijcation Error Rate
In general, classification error rates depend on the size of the labeled classes, and can be deceptively low when the classes have very different sizes (as ours do, since most peptide peaks are low-intensity, not high-intensity). Even random guessing can appear to produce very low emor rates. To compensate for this, we used the ROC data to estimate classification error rates for classes of equal size. This is easily done with the following formula We applied this formula to every point on every ROC curve in Figure 3 . For each curve, we chose the lowest resulting error rate, to indicate the best possible performance for the classifier on the dataset. Table I1 shows the resulting classification error rates for each of the six classifiers on each of the three different datasets, with both MAX-MIN and STD-DEV used to choose specificity + sensitivity 2 error rate = 1 - proteins. The table shows that the classification error rates range from 0.3 to 0.4. In addition, it corroborates some of the results discussed above. For instance, LDA performs the hest across all datasets, while HMMs petform the worst.
VI. CONCLUSIONS AND FUTURE W O R K
In this paper, we applied several well-known classification methods to Peptide Tandem Mass Spectrometry data. We evaluated and compared the methods based on their ability to predict the intensity of peaks in a mass spectrum based on the amino-acid sequence of peptides. Specifically, the methods were required to divide peptides into two classes: those that produce high-intensity peaks, and those that produce lowintensity peaks.
Overall, we found that for our datasets, simple classifiers such as LDA performed well compared with more sophisticated ones, such as QDA and Hidden Markov Models. In the main comparison based on ROC evaluation, LDA has the best generalization performance. In decreasing order of performance, the other classifiers were Logistic regression, Naive Bayes (with 421-component vectors), QDA, K" (with K=50), Naive Bayes (with 21-component vectors), and finally HMMs (with any number of states), which sometimes performed worse than random guessing. The performance of all the methods was quite variable. Misclassification rates for classes of equal size were also estimated, and they corroborate our conclusions drawn from the ROC evaluation.
Several further steps suggest themselves. For instance, the performance of each of the methods might be improved by boosting. Decision trees (which often work well with boosting) could he tried. Clustering methods could also be used to search for structure within each of the labeled classes, in order to provide better priors for the classification methods. In addition, Bayesian inference, bootstrapping and bagging could be used to deal with the problems of overfitting. To prevent over fitting of Hidden Markov Models, we are considering morestructured versions of them, such as Profile Hidden Markov Models, which have significantly fewer panmeters. Finally, we are considering methods for extracting more training data from the MS/MS spectra. In this paper, we considered two methods, MAX-MIN and STD-DEV, hut many other methods are also possible.
